A close-up view of the Hunter syndrome

The Lysosomal Storage disease known as Mucopolysaccharidosis type II, is caused by mutations affecting the iduronate-2-sulfatase required for heparan and dermatan sulfate catabolism. The central nervous system (CNS) is mostly and severely affected by the accumulation of both substrates. The complexity of the CNS damage observed in MPS II patients has been limitedly explored. The use of mass spectrometry (MS)-based proteomics tools to identify protein profiles may yield valuable information about the pathological mechanisms of Hunter syndrome. In this further study, we provide a new comparative proteomic analysis of MPS II models by using a pipeline consisting of the identification of native protein complexes positioned selectively by using a specific antibody, coupled with mass spectrometry analysis, allowing us to identify changes involving in a significant number of new biological functions, including a specific brain antioxidant response, a down-regulated autophagic, the suppression of sulfur catabolic process, a prominent liver immune response and the stimulation of phagocytosis among others

• Autores: Cardona Ramírez, Carolina; Almeciga Diaz, Carlos Javier; Martín, Mercedes; Cardenas, Casimiro; Espejo Mojica, Angela Johana; Lobo, Carolina; Benincore-Flórez, Eliana Patricia
• Tipo de recurso: Article of investigation
• Fecha de publicación: 2024
• Institución: Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
• Repositorio: Repositorio Institucional UDCA
• Idioma: eng
• OAI Identifier: oai:repository.udca.edu.co:11158/5553
• Acceso en línea: https://repository.udca.edu.co/handle/11158/5553; https://doi.org/10.1016/j.bbrc.2024.149490
• Palabra clave: Mucopolisacaridosis II; Espectrometría de Masas; Análisis proteómico; IDS
• Rights: openAccess
• License: https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode.es